Profiel
Momenteel bekleedt Russell P. Wilson de functie van Senior Vice President-Business Development bij Novavax, Inc. Daarvoor bekleedde hij de functie van Chief Financial Officer & Vice President bij Supernus Pharmaceuticals, Inc., Chief Financial Officer, Secretary & Senior VP bij Intercell USA, Inc. en General Counsel bij North American Vaccine, Inc. Hij behaalde een MBA en een graduaatsdiploma aan de Universiteit van Virginia en een doctoraatsdiploma aan de Universiteit van Princeton.
Eerdere bekende functies van Russell Wilson
Bedrijven | Functie | Einde |
---|---|---|
NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 28-03-2012 |
IOMAI CORPORATION | Director of Finance/CFO | 01-08-2008 |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | General Counsel | 01-01-2000 |
SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Opleiding van Russell Wilson
University of Virginia | Graduate Degree |
Princeton University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NOVAVAX, INC. | Health Technology |
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |